Want to join the conversation?
$EQR expects normalized FFO per share of $0.89-0.93 for 4Q15. The difference between 3Q15 normalized FFO of $0.89 per share and the midpoint of 4Q15 guidance of $0.91 per share is due primarily to a positive impact of about $0.02 per share from higher same store net operating income.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?